DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Active, not recruitingOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2025

Conditions
Atrial FibrillationThromboembolism, Venous
Interventions
DRUG

DOACs

outpatients visited in anticoagulation clinics with a prescription of DOAC for atrial fibrillation and venous thromboembolism and concomitant antiepileptic drug will perform a blood draw for measurement of dabigatran, rivaroxaban, apixaban and edoxaban

Trial Locations (1)

00168

Fondazione Policlinico Universitario A.Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER